Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022

Haitao Yang, Xing Meng, Tingyu Zhuang, Cangning Wang, Zhongliang Yang, Taotao Zhu, Mei Li, Yan Zheng, Qianhui Wu, Yaling Hu, Hongjie Yu, Xiaoqiang Liu, Gang Zeng. Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022J. China CDC Weekly, 2023, 5(6): 125-130. DOI: 10.46234/ccdcw2023.023